Today’s AI Top Pick: TCOM

8/4/2026 · Forecast Pure screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · TCOM72%337 resolved forecasts · 45d window · verify →

View the live TCOM price forecast →

Today's pick · Forecast PureTCOMBUY NOW8.6 / 108/4/2026

TCOM is the only name in the pool with genuine multi-timeframe alignment AND a clean fundamental profile AND a non-toxic news backdrop. All four Kronos horizons print positive on the mid/long forecasts: 1h +2.6/+1.44/-2.74, 4h +3.7/+1.18/+13.01, 1d +10.35/+29.32/+24.67, and 1wk +1.42/+5.41/+9.4. That 1d mid-forecast of +29% with the weekly independently corroborating at +9.4% is exactly the kind of internal consistency the lens is built for — you don't see one blown-out single-bar outlier dragging the story. Bullish_prob=1.0 and near_term_bullish=0.8 back the picture. Entry timing is favorable rather than chased. The 1h position-in-range is only 17.06% (with a −2.05% pullback from the 21-bar high) and the weekly is at 39.23% with a −15.75% drawdown — so we are buying into a consolidation after a multi-month cool-off (perfYtd −34.22%, perfYear −22%), not extending a parabolic move. Compare that to APGE, BFH, or SAN which are pinned at 90–100% of range with weekly forecasts of −50% to −67% — classic short-side setups the model is flagging against. Fundamentals are the tiebreaker that pushes TCOM above the other bullish_prob=1 names (DKNG, PONY, NFGC, TEM). Fundamental_score of 8 (top of pool), PE 7.45, fwdPe 11.55, PEG-adjacent growth via epsNextY +17.13, salesYoY +19.28, ROE 20%, profit margin 48.4%, debt/equity 0.19, analyst recom 1.44 (Strong Buy) and 25.6% target upside. DKNG has a PE of 390 and D/E of 3.17; PONY has an operating margin of −239%; NFGC is unprofitable. Only TCOM offers cheap growth + strong forecast. On news: the July 31 antitrust fine headline reads worse than it is — Benzinga's own framing is that Trip.com was 'spared a major overhaul,' i.e., regulatory overhang is resolving at the low end. Citi maintained Buy the same week (PT $62). No dilution, no short-seller report, no guidance cut. Reason to buy TODAY: forecast strength peaks in the mid-window (1d fc_mid +29%), price sits near the bottom of its 1h range, and the regulatory landmine just cleared. Waiting risks entering after the gap.

TCOM forecast chart
Entry zone
$45.80–$46.80 (starter now at $46.50, add on any dip to $45.50–$45.80 which is the 1h range low)
Stop loss
$43.20 (below the 1wk drawdown floor; ~7% risk)
First target
$51.50 (retest of 21-day high area, ~11% gain, aligns with 1d fc_short +10.35%)
Longer target
$58–$60 (Citi PT $62 area and 1d fc_mid +29% projection off current)
Risks
  • China ADR headline/regulatory risk — the July 31 fine was resolved mildly but Beijing anti-monopoly posture can re-escalate; a fresh probe would break the setup
  • 1h position-in-range is 17% but 1d position is 87% — a shakeout back toward $44 is possible before the trend resumes
  • Weekly recent_21bar_pct is −8.93% and dd_from_21bar_high is −15.75%; if it breaks the weekly low, the entire pattern invalidates
  • USD/CNY volatility and Chinese travel-demand data (macro sensitivity above what fundamentals imply)
  • Analyst PTs have been trimmed (Citi cut to $62 from higher), signaling that even bulls are moderating — cap position sizing accordingly
Honorable mentions
TEMKronos bullish_prob=1 with clean multi-TF agreement (1d +9/+47/+28, 1wk +3/+40/+37), price beaten down to 1d position 23.98% with −24.66% drawdown — textbook 'not chasing.' Held back to #2 by fundamental_score −1, operating margin −18.9%, elevated 28.4% short float, and Stifel just lowered PT to $50 (Hold). Higher variance than TCOM but bigger upside if AI-diagnostics thesis works.
DKNGStrong mid/long forecasts (1d +25/+26, 1wk +37/+43) with price at only 15.83% of 1d range and −13.5% drawdown — classic buy-the-dip geometry. Michael Burry disclosed a new long position (positive catalyst). Downgraded from #1 by PE 390, D/E 3.17, and thin operating margin of 0.68% — you're paying for future EPS acceleration (epsNextY +357%), not current cash flow.
Full ranking (30)
#SymbolVerdictScoreRead
1TCOMBUY NOW8.6Only name with all-TF bullish forecast, cheap valuation (PE 7.45, fwdPe 11.55, ROE 20%), and cleanly-resolved regulatory overhang.
2TEMBUY NOW7.4AI-healthcare thesis with 1d fc_mid +47% and price at 24% of range after 25% drawdown — high-variance but forecast-model favorite.
3DKNGBUY NOW7.11wk fc_long +43% and Burry long, but nosebleed PE 390 caps conviction.
4PONYBUY PULLBACK6.5Robotaxi story with 4h fc_long +57%/1d fc_mid +64%, but −239% operating margin means every entry is a coin flip.
51INCH-USDBUY NOW5.9Weekly fc_long +174% with all-TF alignment and positive DeFi liquidity-layer catalyst; crypto beta acknowledged.
6SAFE-USDBUY NOW5.61d bullish across horizons (+15/+12/+17) after −19% dd, near-term bullish 1.0.
7BLAST-USDBUY PULLBACK5.41d fc_long +108% but only one TF available — single-signal risk.
8NFGCBUY PULLBACK5.2Multi-TF gold-junior +34/+72% weekly, but profit margin −368% keeps size tiny.
9FIDA-USDBUY NOW5.11d fc_long +46% off the range low (0%) with near-term bullish 1.0.
10CRMLBUY PULLBACK4.91d fc_mid +40%, but 4h shows −35% recent bar and analyst overvaluation flag — messy.
11AXS-USDBUY PULLBACK4.51d fc_long +64% off deep drawdown but weekly still bleeding (−24%).
12TNSR-USDBUY PULLBACK4.21d fc_long +50% but weekly forecast is −17 to −43%; wait for weekly stabilization.
13GPROBUY PULLBACK4.0Big forecasts (+64% weekly fc_long) but sub-$1 stock with fundamental_score −3.75 — lottery ticket only.
14PBR-AWAIT3.5Cheap (PE 5.5) but Kronos flips bearish beyond 1h (1d fc_long −23%, 1wk −43%).
15ALECWAIT3.3Positive forecasts undercut by GSK ending brain-drug alliance — pipeline reset is a landmine.
16SEIWAIT3.0Wells Fargo upgrade but Kronos weekly fc_long −76%; strong disagreement, sit out.
17SIMOAVOID2.6Fundamentals shine (fwdPe 16.4, PEG 0.21) but every horizon forecasts down 20–70% — model says top.
18SANAVOID2.5Price pinned at 100% of range on 1d/1wk with fc_long −67%; classic top.
19FIXAVOID2.3Weekly fc_long −85% at 71% of range after 33% run — Kronos calling exhaustion.
20DACAVOID2.2RSI 71.3 at 95% of weekly range with fc_long −38% — chase risk despite earnings beat.
21BFHAVOID2.1At 100% of weekly range with 1d fc_mid −41%; RSI 67 — sell setup.
22AGENAVOID2.0RSI 76 and price at 99–100% of 1d/1wk range with fc_short −59%; a blow-off.
23SAVOID1.9Weekly at 100% of range with all-TF negative forecasts (−7 to −30%).
24ZURAAVOID1.8All-TF fc_long negative (−4 to −38%) despite William Blair Outperform.
25SNDAAVOID1.61d fc_long −28% and 1wk −33%; no thesis except analyst PT $50.
26DRTSAVOID1.51d fc_long −68% overwhelms positive trial data; wait for stabilization.
27TRTAVOID1.4PE 308, 1d fc_long −70%, weekly −65% — the AI-GPU order news is priced in.
28BFLYAVOID1.31d fc_long −65% at 98% of range; perfYear +487% — mean reversion setup.
29APGEAVOID1.0RSI 78.6 at 99.75% of weekly range with 1wk fc_long −69%; AbbVie profit cut hangover.
30EXFYAVOID0.9Every TF negative, targetUpsidePct −39.5, fundamental_score −5 — broken.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.